Table 3 Regions-of-interest (ROI) measures by age-matched male group comparisons.
PRE | MALEPRE | PERI | MALEPERI | POST | MALEPOST | |
|---|---|---|---|---|---|---|
ATP/PCr measures | ||||||
Anterior cingulate cortex | 1.06 (0.07) | 1.11 (0.07) | 1.10 (0.04) | 1.12 (0.05) | 1.12 (0.04) | 1.12 (0.05) |
Adjusted by APOE-4 status | 1.05 (0.07) | 1.12 (0.07) | 1.11 (0.04) | 1.10 (0.05) | 1.11 (0.04) | 1.13 (0.05) |
Insula | 1.21 (0.06) | 1.29 (0.07) | 1.24 (0.04) | 1.24 (0.04) | 1.26 (0.03)* | 1.21 (0.05) |
Adjusted by APOE-4 status | 1.20 (0.06) | 1.30 (0.06) | 1.24 (0.04) | 1.23 (0.04) | 1.27 (0.03)* | 1.22 (0.05) |
Inferior parietal lobule | 0.78 (0.07) | 0.85 (0.08) | 0.76 (0.04) | 0.84 (0.04) | 0.83 (0.03) | 0.86 (0.04) |
Adjusted by APOE-4 status | 0.77 (0.08) | 0.86 (0.08) | 0.76 (0.04) | 0.84 (0.04) | 0.83 (0.03) | 0.86 (0.04) |
Middle temporal gyrus | 1.10 (0.04) | 1.17 (0.05) | 1.15 (0.02) | 1.12 (0.3) | 1.19 (0.02)* | 1.10 (0.03) |
Adjusted by APOE-4 status | 1.10 (0.04) | 1.18 (0.04) | 1.15 (0.02) | 1.12 (0.3) | 1.19 (0.02)* | 1.10 (0.03) |
Medial temporal lobe | 1.16 (0.05) | 1.24 (0.05) | 1.22 (0.03) | 1.20 (0.04) | 1.21 (0.03) | 1.19 (0.04) |
Adjusted by APOE-4 status | 1.15 (0.05) | 1.26 (0.05) | 1.22 (0.03) | 1.20 (0.04) | 1.22 (0.03) | 1.19 (0.04) |
Medial frontal gyrus | 1.05 (0.06) | 0.99 (0.06) | 1.04 (0.03) | 0.98 (0.04) | 1.07 (0.03)* | 0.95 (0.04) |
Adjusted by APOE-4 status | 1.04 (0.06) | 1.01 (0.06) | 1.05 (0.03) | 0.97 (0.04) | 1.07 (0.03)* | 0.96 (0.04) |
Superior frontal gyrus | 0.95 (0.05) | 0.86 (0.06) | 0.94 (0.03)* | 0.84 (0.03) | 0.96 (0.03)* | 0.83 (0.04) |
Adjusted by APOE-4 status | 0.94 (0.05) | 0.87 (0.05) | 0.95 (0.03)* | 0.84 (0.04) | 0.96 (0.03)* | 0.84 (0.04) |
Amyloid-β load | ||||||
AD-mask SUVR | 1.01 (0.05) | 0.92 (0.05) | 1.20 (0.05)* | 0.92 (0.06) | 1.29 (0.05)* | 0.93 (0.06) |
Adjusted by APOE-4 status | 1.01 (0.05) | 0.92 (0.05) | 1.21 (0.05)* | 0.91 (0.06) | 1.29 (0.05)* | 0.93 (0.06) |
AD-mask SUVR by APOE-4 status | ||||||
APOE-4− | 0.94 (0.07) | 0.86 (0.07) | 1.14 (0.06) | 0.88 (0.08) | 1.32 (0.07)* | 0.93 (0.09) |
APOE-4+ | 1.07 (0.07) | 0.96 (0.08) | 1.32 (0.09)* | 0.93 (0.10) | 1.25 (0.05)* | 0.95 (0.10) |